Abstract
A series of new 16β-azolyl-3β-amino-5α-androstane derivatives were synthesized and characterized. The new compounds were screened for their anticancer activity against the human cancer cell lines SW480, A549, HepG2, HeLa and SiHa in vitro using the MTT assay. The results of the in vitro study showed that a number of compounds have shown IC(50) values lower than 20 μM against the five cancer cell lines.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Androstanes / chemical synthesis*
-
Androstanes / chemistry
-
Androstanes / pharmacology*
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Benzimidazoles / chemical synthesis*
-
Benzimidazoles / chemistry
-
Benzimidazoles / pharmacology*
-
Cell Line, Tumor
-
Crystallography, X-Ray
-
Drug Screening Assays, Antitumor
-
Humans
-
Inhibitory Concentration 50
-
Magnetic Resonance Spectroscopy
-
Models, Molecular
-
Triazoles / chemical synthesis*
-
Triazoles / chemistry
-
Triazoles / pharmacology*
Substances
-
Androstanes
-
Antineoplastic Agents
-
Benzimidazoles
-
Triazoles